Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-08-24
1994-11-01
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549371, A61K 3135, C07D30914
Patent
active
053608186
ABSTRACT:
The present invention provides compounds having the formula ##STR1## wherein R.sub.1 is alkyl, alkenyl and alkynyl having from 2 to about 20 carbon atoms; R.sub.2, R.sub.3 and R.sub.6 are independently H, phenyl or alkyl having from 1 to about 20 carbon atoms; and R.sub.4 and R.sub.5 are independently H, R.sub.6 imino, or amidino, and pharmaceutically acceptable salts thereof which are useful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
REFERENCES:
patent: 2254876 (1941-09-01), Senkus
patent: 2568555 (1951-09-01), Moore
patent: 2882275 (1959-04-01), Meiser et al.
patent: 3060196 (1962-10-01), Grob
patent: 3459771 (1969-08-01), Hitz et al.
patent: 3621033 (1971-11-01), Houlihan
patent: 4816450 (1989-03-01), Bell et al.
Braun, C. E., J. Amer. Chem. Soc. 55: 1280-1285 (1933).
Castagna et al., J. Biol. Chem. 257: 7847, 1982.
Grunicke et al., Adv. Enzyme Regul. 28: 201, 1989.
Tritton et al., Cancer Cells 2: 95-102, 1990.
Schachtele et al., Biochem. Biophy. Res. Commun. 151: 542, 1988.
Hannun et al., J. Biol. Chem. 262: 13620, 1987.
Yamada et al., Biochem. Pharmacol. 37: 1161, 1988.
McIntyre et al., J. Biol. Chem. 262: 15730, 1987.
Lambreth et al., J. Biol. Chem. 263: 3818, 1988.
Pittet et al., J. Biol. Chem. 262: 10072, 1987.
Gaudry et al., Immunology 63: 715, 1988.
Wilson et al., J. Biol. Chem. 261: 12616, 1986.
Fujita et al., Biochem. Pharmacol. 35: 4555, 1986.
Berkow et al., J. Leukoc. Biol. 41: 441, 1987.
Salzer et al., Biochem. Biophys. Res. Commun. 148: 747, 1987.
Kramer et al., J. Biol. Chem. 262: 5876, 1989.
Dewald et al., Biochem. J. 264: 879, 1989.
Stoffel et al., Hoppe-Seyler's Z. Physiol. Chem., 348: 1561-69, 1967.
Gigg and Warren, J. Chem. Soc. (C), 2661, 1968.
Eliel et al., J. Org. Chem., 42(9): 1533, 1977.
Kaloustian et al., J. Am Chem. Soc. 98(4): 956, 1976.
Mori et al., Tetrahedron Letters, 22(44): 4429, 1981.
Saitoh et al., Bull. Chem. Soc. Jpn., 54: 488, 1981.
Garner et al., J. Org. Chem. 52(12) 2361, 1987.
Hino et al., J. Chem. Soc. Perkin Trans. I: 1687, 1986.
Kiso et al., Carbohydrate Res., 158: 101-111, 1986.
Herold, Helvetica Chimica ACTA, 71: 354, 1988.
Ohashi et al., Tetrahedron 45(9): 2557, 1989.
Nakagawa et al., J. Chem. Soc., Chem. Commun. 603-605, 1990.
Umemura and Mori, Agric. Biol. Chem., 46(7): 1797, 1982.
Nakagawa et al., Tetrahedron Letters 28(50): 6281, 1987.
Kodato et al., Tetrahedron 45(23): 7263, 1989.
Merck Index, 10th edition, Merck & Co., Inc., Rahway, N.J., 1983, p. 869.
Jiang Jack B.
Johnson Mary G.
Nichols Jeffrey
Chan Nicky
Sphinx Pharmaceuticals Corporation
LandOfFree
1,3-dioxane derivatives having protein kinase C inhibitory activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dioxane derivatives having protein kinase C inhibitory activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dioxane derivatives having protein kinase C inhibitory activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802891